Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2‐Low Breast Cancer With Cancer‐Related Microangiopathic Hemolytic Anemia: A Case Report
Authors:
Open Access
- 11 October 2025
- journal article
- Published by Wiley in Cancer Innovation
- Vol. 4 (5)
Abstract
The diagnosis of cancer‐related microangiopathic hemolytic anemia (CR‐MAHA) in patients with breast cancer is often delayed, and this condition is associated with high mortality. A 71‐year‐old female with CR‐MAHA secondary to bone marrow metastasis received trastuzumab deruxtecan (T‐DXd) after first‐line chemotherapy failure and achieved partial hematological remission. Treatment was discontinued because of interstitial lung disease (ILD). Early antitumor therapy is crucial; antibody‐drug conjugates such as T‐DXd offer promise, but vigilance for adverse effects is needed.Keywords
This publication has 12 references indexed in Scilit:
- Occult Disseminated Metastatic Breast Carcinoma Presenting as Acquired Thrombotic Thrombocytopenic PurpuraCase Reports in Oncology, 2021
- How I treat microangiopathic hemolytic anemia in patients with cancerBlood, 2021
- Case Report: Microangiopathic Hemolytic Anemia With Normal ADAMTS13 ActivityFrontiers in Medicine, 2021
- Characteristics and outcome of breast cancer-related microangiopathic haemolytic anaemia: a multicentre studyBreast Cancer Research, 2021
- Cancer-related microangiopathic haemolytic anaemiaBMJ Case Reports, 2017
- Microangiopathic Hemolytic Anemia and Thrombocytopenia in Patients With CancerJournal of Oncology Practice, 2016
- Pathophysiology of tumour-induced microangiopathic haemolytic anaemiaBMJ Case Reports, 2016
- Syndromes of Thrombotic MicroangiopathyNew England Journal of Medicine, 2014
- Hemolytic Anemia and Metastatic Carcinoma: Case Report and Literature ReviewLaboratory Medicine, 2014
- American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial PneumoniasAmerican Journal of Respiratory and Critical Care Medicine, 2002